Register Cart 0

Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back Subscribe

Editorial

Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents

Author(s): Antonio Di Stefano* and Marcella Reale*

Volume 17, Issue 2, 2017

Page: [89 - 89] Pages: 1

DOI: 10.2174/187152491702170712214058

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

22

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Delayed Treatment with Nicotinamide Inhibits Brain Energy Depletion,Improves Cerebral Microperfusion, Reduces Brain Infarct Volume, but does not Alter Neurobehavioral Outcome Following Permanent Focal Cerebral Ischemia in Sprague Dawley Rats
Current Neurovascular Research

Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy

Neurological Substrate of Central Auditory Processing Deficits in Children
Current Pediatric Reviews

The Importance of Steroidomics in the Study of Neurodegenerative Disease and Ageing
Combinatorial Chemistry & High Throughput Screening

α-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets

Role of Monocarboxylate Transporters in Drug Delivery to the Brain
Current Pharmaceutical Design

Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease
Current Drug Targets

Protein Folding, Unfolding and Misfolding: Role Played by Intermediate States
Mini-Reviews in Medicinal Chemistry

A Genomic and Epigenomic Approach for Studying Neuropsychiatric Disorders Associated to Early-life Stress: Part II
Current Genomics

Nanoparticles, Neurotoxicity and Neurodegenerative Diseases
Current Drug Metabolism

Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
CNS & Neurological Disorders - Drug Targets

Integration of <sup>18</sup>FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease
Current Alzheimer Research

Heat Shock Response Regulates Insulin Sensitivity and Glucose Homeostasis: Pathophysiological Impact and Therapeutic Potential
Current Diabetes Reviews

Nutraceuticals: A Comparative Analysis of Regulatory Framework in Different Countries of the World
Endocrine, Metabolic & Immune Disorders - Drug Targets

The Role of Chemokines in Alzheimer's Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets

Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting
CNS & Neurological Disorders - Drug Targets

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
Recent Patents on CNS Drug Discovery (Discontinued)

Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
Current Drug Targets

Meet Our Editorial Board Member
Current Medicinal Chemistry

Editorial [Hot Topic: New Developments in Therapy for Oxidative Stress-Related Diseases: Pathophysiological and Clinical Consequences (Executive Guest Editor: Victor M. Victor)]
Current Pharmaceutical Design

© 2024 Bentham Science Publishers | Privacy Policy